Merck KGaA (MKGAF)
OTCMKTS · Delayed Price · Currency is USD
149.71
+2.26 (1.53%)
Jan 6, 2026, 3:58 PM EST
Merck KGaA Market Cap
Merck KGaA has a market cap or net worth of $64.24 billion as of January 6, 2026. Its market cap has increased by 0.49% in one year.
Market Cap
64.24B
Enterprise Value
75.04B
Revenue
24.96B
Ranking
n/a
PE Ratio
18.52
Stock Price
$149.71
Market Cap Chart
Since April 7, 1997, Merck KGaA's market cap has increased from 6.76B to 64.24B, an increase of 849.93%. That is a compound annual growth rate of 8.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 62.69B | -0.02% |
| Dec 30, 2025 | 62.70B | -0.65% |
| Dec 30, 2024 | 63.11B | -8.87% |
| Dec 29, 2023 | 69.25B | -17.61% |
| Dec 30, 2022 | 84.06B | -24.78% |
| Dec 30, 2021 | 111.75B | 49.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 719.98M |
| Elite Pharmaceuticals | 537.20M |
| Northwest Biotherapeutics | 397.78M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 342.98M |
| Silence Therapeutics | 290.49M |